iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Trading 0.5% Higher – Time to Buy?

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN)’s stock price traded up 0.5% during mid-day trading on Wednesday . The stock traded as high as $23.81 and last traded at $23.81. 336 shares changed hands during mid-day trading, a decline of 44% from the average session volume of 601 shares. The stock had previously closed at $23.68.

iShares Neuroscience and Healthcare ETF Price Performance

The company has a market capitalization of $3.55 million, a price-to-earnings ratio of 28.31 and a beta of 0.72. The business has a fifty day moving average price of $25.15 and a 200 day moving average price of $25.75.

Hedge Funds Weigh In On iShares Neuroscience and Healthcare ETF

A hedge fund recently bought a new stake in iShares Neuroscience and Healthcare ETF stock. Jane Street Group LLC acquired a new stake in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,150 shares of the company’s stock, valued at approximately $254,000. Jane Street Group LLC owned 6.77% of iShares Neuroscience and Healthcare ETF as of its most recent SEC filing.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.